Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Bad idea?

fuzzyjr

Dec 17, 2023 03:52PM

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Bad idea?

in response to

Bad idea?

fuzzyjr

posted on Dec 17, 2023 04:01PM

Obviously this would dilute the possible revenue stream even further, making current zen shareholders not bery happy?? Or does rvx have enough in the closet to make this somewhat viable?

1 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply